PURPOSE: To investigate the use of magnetic resonance (MR) imaging wit
h dynamic gadopentetate dimeglumine enhancement in hilar cholangiocarc
inoma. MATERIALS AND METHODS: Twenty-four patients (14 men, 10 women;
aged 27-78 years; mean age, 51 years) with hilar cholangiocarcinoma un
derwent TZ-weighted spin-echo MR imaging in the axial plane and multis
ection, breath-hold, fast low-angle shot (FLASH) MR imaging in the cor
onal oblique plane before and at 30, 60, 90, and 120 seconds after bol
us injection of gadopentetate dimeglumine. Morphologic features were r
ecorded, and contrast medium enhancement characteristics and contrast-
to-noise ratios were calculated for each sequence. RESULTS: All the le
sions were hyperintense on T2-weighted spin-echo images and hypointens
e on FLASH images. On dynamic gadolinium-enhanced images, progressive
heterogeneous enhancement was seen in all patients. Intrahepatic ducta
l dilatation was present in every patient. Intraluminal components wer
e seen in 11 patients, lobar atrophy in 12, and segmental portal venou
s occlusion or stenosis in 13. Satellite lesions were present in four
patients, and hilar lymph nodal enlargement in 11. Contrast-to-noise r
atios were statistically significantly higher on T2-weighted spin-echo
images than on all other images. CONCLUSION: Hilar cholangiocarcinoma
s have consistent enhancement and morphologic features that can be dem
onstrated with dynamic contrast-enhanced MR imaging.